The oncology information systems market is projected to reach USD 9.5 billion by 2025 from USD 6.7 billion in 2020, at a CAGR of 7.4% during the forecast period. Growth of the market is mainly attributed to the technological advancements; increasing incidences of cancer cases, and growing public and private investments, funding, and grants are driving the global oncology information systems market. However, complex regulatory frameworks that delay the approval of new oncology information systems is expected to challenge market growth to a certain extent.
In terms of products, Software segment to register significant growth during the forecast period. Based on the product, the oncology information systems market is segmented into software, and professional services.Software products include patient information systems, treatment planning systems, and treatment management systems & medical image analysis systems.
Significant growth of the orthopedic implants and devices segment is attributed to the ongoing product approval of oncology informatio solutions , increasing agreement between OIS vendors and multinational hospitals for the impementation of oncology information systems , and the increasing availability of these products in major markets. These software allow early recovery of the cancer patients and planned procedure which have led to the growth of this segment.
In terms application, radiation oncology segment to register significant growth during the forecast period. Based on the application, the oncology information systems market is segmented into radiation oncology, medical oncology and surgical oncology.The radiation oncology segment accounted for a larger share of in the market in 2019.
The increasing prevalence recurrence of secondary cancer cases , growing number of radiosurgery procedures and increasing customer base for oncology information systems for radiology are factors expected to drive the growth of this market segment in the coming years.
Hospitals & Diagnostic Imaging Centers segment is expected to account for the largest share of the oncology information systems market, by the end user” ` On the basis of end-users, the oncology information systems market has been segmented into hospitals & diagnostic imaging centers, ablation & cancer care centers, government institutions, and research facilities.The growth of this segment is attributed to the significant number of availability of state-of-the-art facilities for diagnosis, treatment, and disease management, as well as trained personnel, has ensured a steady demand for hospital-based care and the growing number of hospitals across major markets.
The inflow of cancer patients is considerably higher in hospitals as compared to other healthcare settings, which is another key driver for market growth. More radiosurgery procedures are conducted in hospitals than in other medical facilities, contributing to the large share of this end-user segment.
Asia Pacific market is expected to grow at the highest CAGR during the forecast period. The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period majorly due to the heavy burden of cancer, rising healthcare expenditure, and increasing geriatric population prone to develop cancer. Apart from this, the rising number of hospitals and cancer care centers in the APAC region is expected to propel the market for foot and ankle devices.
A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16% • By Designation: C-level–10%, Director-level–14%, and Others–76% • By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%
Some of the prominent players in the oncology information systems market include Koninklijke Philips N.V. (Netherlands), Varian Medical Systems, Inc (US), McKesson Corporation (US), Siemens Healthineers (Germany), Elekta AB (Sweden), Epic Systems Corporation (US), IBM (US), Cerner Corporation (US), Advanced Data Systems (US), Bogardus Medical Systems, Inc (US), F. Hoffmann-La Roche AG (Switzerland), AmerisourceBergen Corporation (US), GE Healthcare (US), Accuray Incorporated (US), OPTUM (a part of UnitedHealth Group) (US), Allscripts Healthcare Solutions, Inc. (US), MICA Information Systems, Inc. (US), CureMD Healthcare (US), EndoSoft LLC (US), and RaySearch Laboratories AB (Sweden), among others.
Research Coverage This report studies the oncology information systems market based on product, application, end user, and region.It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders.
Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers: • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the oncology information systems market • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the oncology information systems market • Market Development: Comprehensive information on lucrative emerging regions • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the oncology information systems market • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
Our reports have been used by over 10K customers, including:
The global eHealth market size is projected to reach USD 193.8 billion by 2025 from USD 69.5 billion in 2020, at a CAGR of 22.8% during the forecast period. Market growth is attributed to the rising per capita income in developed and developing countries and technological advancements introduced in the eHealth solutions. By...
The global healthcare gamification market is expected to reach US$35,982.7 million in 2027 from US$ 3,072.5 million in 2019. The market is estimated to grow with a CAGR of 36.2% from 2020-2027. The growth of the market is attributed to factors such as increasing adoption of gamification in healthcare and rise in number of technology launches....
The beta-glucan market is estimated at USD 403.8 million in 2020 and is projected to grow at a CAGR of 7.6%, to reach USD 628.3 million by 2026. The ongoing health and wellness trend is spreading across the world, with the growing consumer awareness regarding dietary deficiency and the health benefits of consuming fiber. Nowadays, consumers...
The propelling factors for the growth of the apheresis market include the increasing number of diseases, a rise in the demand for blood components and associated safety, technological advancement in the development of new apheresis techniques, and rise in the reimbursement policies and funding for apheresis procedures. With the increasing...
The pressure ulcer treatment market is expected to register a CAGR of 6.3% during the forecast period. Pressure ulcers also are known as bedsores or pressure sores, are injuries caused to skin and tissues primarily caused by prolonged pressure on the skin. Pressure ulcers can range in severity from patches of discolored skin to open wounds...
The global medical engineered materials market size is projected to reach USD 29.1 billion by 2025 from USD 15.8 billion in 2020, at a CAGR of 13.0%. This growth is attributed to the increasing healthcare expenses in emerging economies, and rising geriatric population increasing need of advanced medical technologies and devices. Also, innovations...
The artificial intelligence (AI) in healthcare diagnosis market was valued at US$ 3,639.02 million in 2019 and is projected to reach US$ 66,811.97 million by 2027; it is expected to grow at a CAGR of 44.0% during 2020–2027. The growth of the market is mainly attributed to factors such rising adoption of AI in disease identification and diagnosis,...
The robotic endoscopy devices market was valued at approximately USD 1,576.34 million in 2020 and is expected to witness a revenue of USD 3,222.87 million in 2026, with a CAGR of 12.45% over the forecast period. The outbreak of the COVID-19 pandemic is expected to have a significant impact on the Robotic Endoscopic Devices market. The...
296 pages •
By The Business Research Company
• Mar 2021
Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global vascular endothelial growth factor (VEGF) inhibitor market. Description: Where...
The Asia Pacific artificial intelligence (AI) in healthcare market is expected to reach US$ 17,797.42 million in 2027 from US$ 622.92 million in 2019. The market is estimated to grow with a CAGR of 50.8% from 2020 to 2027. The growth of this market is attributed to the key driving factors such as the increasing public-private investments...
Medical Technology Density
Health Provider Density
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.